Parkinson's Disease In The Crossfire 2011
2011 Webcasts
New information for neurologists and other medical professionals broadcast from the Newseum in Washington, DC.
Research Update: Part 1
1 hour
Topic segments will include:
Release Date: June 30, 2011
Expiration Date: June 30, 2013
Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.
How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.
Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:
- Identify the benefits and complications of levodopa
- Discuss the implications of recent studies evaluating dosing manipulations of levodopa
- Describe the Parkinson's Disease patients who are most likely to develop dyskinesias
- Explain the pros and cons of dopamine agonists
- Describe the recent information about deep brain stimulation
- Explain how gene therapy could impact treatment options available for Parkinson's Disease
Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Peer Health Communications. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.
This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Peer Health Communications.
Research Update: Part 2
1 hour
Release Date: August 1, 2011
Expiration Date: August 1, 2013
Target Audience
This activity is intended for neurologists and other medical professionals with a specific interest in the management of Parkinson's Disease.
How to get CME credit
To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.
Learning Objectives:
At the conclusion of this continuing medical education activity, participants should be able to:
- Define the types of study designs for evaluating neuroprotection
- Identify the difficulties in evaluating neuroprotection
- Discuss the clinical implications of different patient evaluation strategies
- Identify the different agents being evaluated in ongoing neuroprotection trials
Accreditation
This educational activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Peer Health Communications. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Ciné-Med, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure statement
Ciné-Med, In accordance with the ACCME's Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.
This continuing medical education activity is jointly sponsored by Ciné-Med, Inc. and Peer Health Communications.